Enhancement of anti-inflammatory and anti-tumorigenic properties of 3D-spheroid formed mesenchymal stem cells derived from rheumatoid arthritis joints

Current studies have revealed the capacity of mesenchymal stem cells (MSCs) in term of immunomodulatory properties, and this distinct potential is downgraded according to the disease duration of patients-derived MSCs. In order to enhance the immunomodulatory and anti-tumorigenic properties of the rheumatoid arthritis (RA) joints-derived MSCs, we aggregate synovial fluid-derived MSCs from RA joints (RA-hMSCs) into 3D-spheroids by the use of hanging drop culture method. Cells were isolated from synovial fluids of RA joints with longstanding active status over 13 years. For aggregation of RA-hMSCs into 3D-spheroids, cells were plated in hanging drops in 30 μL of advanced DMEM (ADMEM) containing 25,000-30,000 cells/ drop and cultured for 48 h. To analyze the comparative immunomodulatory effects of 3D-spheroid and 2D monolayer cultured RA-hMSCs and then cells were cultured in ADMEM supplemented with 20% of synovial fluids of RA patients for 48 h and were evaluated by qRT-PCR for their expression of mRNA levels of inflammatory and antiinflammatory markers. Cellular aggregation of RA-hMSCs was observed and cells were aggregate into a single sphere. Following treatment of RA patient’s synovial fluids into the RA-hMSCs, spheroids formed RA-hMSCs showed significantly (p < 0.05) higher expression of TNFα stimulated gene/protein 6 (TSG-6) than the monolayer cultured RAhMSCs. Therefore, the 3D-spheroid culture methods of RA-hMSCs were more effective than 2D monolayer cultures in suppressing inflammatory response treated with 20% of RA-synovial fluids by expression of TNFα (TSG-6) according to the immune response and enhanced secretion of inflammatory factors..

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:37

Enthalten in:

Journal of Animal Reproduction and Biotechnology - 37(2022), 4, Seite 246-254

Sprache:

Englisch ; Koreanisch

Beteiligte Personen:

Seung-Chan Lee [VerfasserIn]
Chae-Yeon Hong [VerfasserIn]
Yong-Ho Choe [VerfasserIn]
Tae-Seok Kim [VerfasserIn]
Won-Jae Lee [VerfasserIn]
Gyu-Jin Rho [VerfasserIn]
Sung-Lim Lee [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.e-jarb.org [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

3d-spheroid
Biotechnology
Immunomodulation
Internal medicine
Medicine (General)
Mesenchymal stem cell
Rheumatoid arthritis
Synovial fluid

doi:

10.12750/JARB.37.4.246

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ004461924